Andaç Salman

25PUBLICATIONS
108CO-AUTHORS
AllergyMedical devicesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 26, 2026
Biomarkers in atopic dermatitis: Current evidence and unmet needs.

|Feb 06, 2026
The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

T Zuberbier, Z Abdul Hameed Ansari, A H Abdul Latiff

|Oct 08, 2024
Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study.

R Soegiharto, M Alizadeh Aghdam, J A Sørensen

|Jul 05, 2024
Emerging Systemic Treatment Options in Atopic Dermatitis.

Andaç Salman, Ana M Giménez-Arnau

|Nov 07, 2021
Real-life effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis.

Andac Salman, Özlem Apti Sengun, Meryem Aktas

|Jun 22, 2021
Remission of chronic spontaneous urticaria following omalizumab with gradually extended dosing intervals: Real-life data.

Andac Salman, Meryem Aktas, Ozlem Apti Sengun

Pageof 5

Frequent Collaborators

4 joint publications

Ana M Giménez-Arnau

3 joint publications

Jonathan A Bernstein

3 joint publications

Ivan Cherrez-Ojeda

3 joint publications

Emek Kocatürk